LEP and breast neoplasm: In this study, we provide evidence that obese hyperleptinemic mice not only exhibit higher breast tumor burden in comparison to lean mice but are also refractory to tamoxifen treatment forming the rationale of our work that the elevated levels of leptin in obese state may modulate the underlying signaling mechanisms to block tamoxifen.